Natalizumab: Immune effects and implications for therapy
- 21 April 2006
- journal article
- editorial
- Published by Wiley in Annals of Neurology
- Vol. 59 (5), 731-732
- https://doi.org/10.1002/ana.20877
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Immune surveillance in multiple sclerosis patients treated with natalizumabAnnals of Neurology, 2006
- Natalizumab effects on immune cell responses in multiple sclerosisAnnals of Neurology, 2006
- Evaluation of Patients Treated with Natalizumab for Progressive Multifocal LeukoencephalopathyNew England Journal of Medicine, 2006
- A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple SclerosisNew England Journal of Medicine, 2006
- Natalizumab plus Interferon Beta-1a for Relapsing Multiple SclerosisNew England Journal of Medicine, 2006
- Natalizumab and PMLNature Neuroscience, 2005
- A Controlled Trial of Natalizumab for Relapsing Multiple SclerosisNew England Journal of Medicine, 2003